- Report
- July 2021
- 120 Pages
Global
From €2946EUR$3,280USD£2,523GBP
€3682EUR$4,100USD£3,154GBP
- Report
- May 2024
- 140 Pages
Global
From €4445EUR$4,949USD£3,807GBP
- Report
- July 2023
- 220 Pages
Global
€4306EUR$4,795USD£3,688GBP
- Report
- April 2024
- 80 Pages
China
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
France
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
Germany
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
India
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1347EUR$1,500USD£1,154GBP
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
United States
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 100 Pages
Africa
From €1796EUR$2,000USD£1,538GBP
- Report
- April 2022
- 120 Pages
Africa, Middle East
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2022
- 325 Pages
Global
From €3233EUR$3,600USD£2,769GBP
- Report
- April 2022
- 120 Pages
Europe
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2022
- 101 Pages
North America
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2022
- 121 Pages
Asia Pacific
From €1347EUR$1,500USD£1,154GBP
- Report
- November 2023
- 76 Pages
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- November 2022
- 150 Pages
Global
From €4356EUR$4,850USD£3,730GBP

Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more